On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach for major depressive disorder pioneered by Nolan Williams, M.D…
Read More
TMS (transcranial magnetic stimulation), a form of non-invasive brain stimulation used to treat depression, has shown its ability to reduce symptoms in many thousands of patients in the years since…
Read More
Researchers have reported that the brain circuitry underlying depression is the same or similar in a wide variety of patients and circumstances, and that it is similar to circuitry affected when…
Read More
Researchers have obtained encouraging results in an early test of an accelerated form of non-invasive brain stimulation to treat major depressive disorder.
Read More
Impaired cognition—operations of the brain that enable people to understand and react to the world that surrounds them—is one of the aspects of schizophrenia that makes it hard for patients to…
Read More
